Naava raises over EUR 3 million, opens US factory
The company will open its first international production facility in New Jersey this spring, from where it will serve especially the New York metropolitan area.
Finnish biopharma firm bags almost EUR 2 million
Desentum, a biopharmaceutical company developing next generation immunotherapy to fight allergies, has secured funding to advance their treatment targeting birch pollen allergy.
Butterfly Ventures hooks up with Capital A Partners
Finnish investment company Butterfly Ventures has established a new fund, Butterfly Venture Fund III, together with US- and Sweden-based Capital A Partners.
WordDive closes EUR 1.27 million crowdfunding round
Finnish language learning mobile and online application WordDive has secured 1.27 million euros via the Invesdor crowdfunding platform.
TalentAdore goes global with new funding
Finnish TalentAdore, which is going to revolutionarise recruitment communications, completed a major funding round worth almost a million euros.
Visedo raises EUR 20 million to take global lead
A Finnish company Visedo, which specialises in electric powertrains and components, has collected a financing package of 20 million euros.
Two Finnish professors granted EUR 2 million each
Professor Anna-Liisa Laine has received the European Research Council (ERC) Consolidator Grant of two million euros, while professor Robin Ras was granted nearly the same amount by the ERC for his research into non-wetting surfaces.
Plantui plants seeds for growth
Finnish design and food company Plantui has seen its sales grow in Europe and Southeast Asia, which has been boosted by more than a million euros in equity investments raised during 2016.
Tilt Biotherapeutics lands EUR 4 million in funding
The Finnish oncolytic immunotherapy startup has raised almost ten million euros in funding to progress its lead candidate into phase I clinical trials.
Rocsole secures funding from Shell
Finnish tomography company Rocsole’s additional funding round was led by Shell Technology Ventures (STV), the corporate venture capital arm of Royal Dutch Shell.